Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR1282 is a microRNA gene (non-protein-coding) whose mature RNA product regulates gene expression post-transcriptionally, primarily by binding to target mRNAs and inducing their degradation or translational arrest. Changes in its expression have been implicated as diagnostic or prognostic biomarkers in various disease processes, including non-small cell lung cancer. It acts as part of the gene regulatory network, influencing cell proliferation, survival, and other cellular processes by modulating target gene expression[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 1282 (mir-1282) (MIR1282 or mir-1282).